NovoCure NVCR Japan — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's japan — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's japan — net revenues?
- NovoCure (NVCR) reported japan — net revenues of $10.24M in Q1 2026.
- How has NovoCure's japan — net revenues changed year-over-year?
- NovoCure's japan — net revenues increased by 17.6% year-over-year, from $8.71M to $10.24M.
- What is the long-term trend for NovoCure's japan — net revenues?
- Over 4 years (2021 to 2025), NovoCure's japan — net revenues has grown at a 2.2% compound annual growth rate (CAGR), from $34.64M to $37.79M.
- What does japan — net revenues mean?
- This metric represents the total gross sales generated from the sale of medical devices and related services within the Japanese geographic market, net of returns and allowances. It serves as a key indicator of the company's commercial penetration and market adoption of its oncology treatment technologies in this specific region. Tracking this revenue stream helps investors assess the company's international growth strategy and the effectiveness of its local distribution and regulatory efforts.